Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Neurodegenerative disease in children might respond to neurosteroids

12.07.2004


Scientists studying mice have identified a possible strategy for slowing a rare, fatal childhood neurodegenerative disease known as Niemann-Pick type C, in which brain cells accumulate fat and die. The finding could also have implications for treating other neurodegenerative disease, they say.



In their study, published in the July issue of Nature Medicine, the team discovered that the synthesis of neurosteroid hormones in the brain -- a process known as neurosteroidogenesis -- is severely disrupted in mice that naturally develop the disease. They then determined that replenishing the depleted neurosteroid hormone allopregnanolone, the prime casualty of the disruption, significantly delayed the onset of some of the animals’ neurological deficits, and doubled their lifespan. The treatment was particularly potent when administered early in the animals’ life. (Video clip available.)

"The results were astounding," says senior author Synthia Mellon, PhD, professor of obstetrics, gynecology and reproductive sciences at University of California, San Francisco.


While the treatment did not target the cause of the disease -- a mutation in one of two genes that disrupts the transport of cholesterol within all cells of the body -- nor cure it, the therapy substantially delayed the onset of weight loss, motor coordination, mobility -- and death. It also significantly delayed the accumulation of fats in cortical cells, and the death of some neurons in the cortex and cerebellum. The study was not designed to test intellectual function, another component of the disease.

Loss Of Neurosteroids In Neurodegeneration

"The finding suggests that the progressive loss of neurosteroids contributes to neuronal degeneration in NP-C mice," says Mellon. "We didn’t cure the problem. There’s still a big clog in the cell, but we’ve circumvented it. We’ve treated downstream consequences of that clog."

Scientists do not know if neurosteroid synthesis is disrupted in children with the disease, so the potential efficacy of allopregnenolone in children with NP-C cannot be predicted, says Mellon. However, allopregnanolone is produced naturally in humans, and provoked no evident side effects when administered to the NP-C mice. Thus, if the neurosteroid hormone is depleted in patients, it could prove a tactic for delaying the onset or progression of some symptoms of the disease.

To determine neurosteroidogenesis activity in children with NP-C, scientists could compare brain tissue from autopsied NP-C patients with that from children who died from unrelated causes. Mellon says she and colleagues hope to be able to initiate pre-clinical studies aimed at determining safety, safe dosage and any possible side effects of allopregnenolone, with an eye to optimizing dosage and carrying out a clinical trial.

If the therapy worked, it would signify a major advance, as scientists have not made headway in repairing the culprit gene, discovered in 1997, or the protein it synthesizes. Although clinical manifestations are varied and can present at any time from intrauterine life to adulthood, patients often begin demonstrating motor and intellectual decline during late childhood, and die between the ages of eight and eighteen. The disease, which also causes enlargement of the liver, occurs in about 1 in 150,000 children.

Illuminating The Role Of Neurosteroids

The finding, in broader terms, provides some of the strongest evidence to date that neurosteroids may play an important role in neurological function in humans, says Mellon. If synthesis of these steroid hormones is found to be disrupted in other neurodegenerative diseases -- a question that has just begun to be investigated -- neurosteroid therapy could prove effective in stalling them, she says.

Like most other steroid hormones, neurosteroids are derived from cholesterol, a lipid that plays an important role in the formation of cell membranes. But while much is known about the role of other steroid hormones, such as testosterone, scientists are only beginning to understand the role of those that function in the brain. Neurosteroids are known to affect neuronal growth and differentiation and to modulate various moods and reactions via neurotransmitter receptors, including GABA. However, says Mellon, scientists generally have presumed that neurosteroids play a supportive, rather than an essential, role in neurological function.

The research team, whose scientific interest is illuminating the role of neurosteroids, suspected that neurosteroid synthesis would be disturbed in NP-C, due to disruption of cholesterol transport within cells, which leads to the accumulation of cholesterol and other lipids in cellular compartments. Their theory was bolstered by the fact that mice with NP-C have below normal concentrations of testosterone and underdeveloped reproductive organs, suggesting that, at least, the synthesis of sex steroid hormones in the testes is disrupted in the disease.

To test their hypothesis, the scientists compared the brains of normal, so-called "wild type," mice, with those of animals with NP-C. The results were dramatic. While neurosteroidogenesis was not affected in NP-C mice prenatally, the impact began at birth and increased over time. The quantity of pregnenolone, the first steroid produced from cholesterol, was significantly decreased. The quantity of allopregnanolone, which is converted from pregnenolone, was diminished even further.

Supporting this finding, the two enzymes that synthesize allopregnanolone, 3a-hydroxysteroid dehydrogenase and 5a-reductase, were significantly depleted in all principal brain regions (the cortex, the midbrain and the hindbrain) by birth, and were reduced to irrelevant quantities by 10 weeks.

The team then examined the impact of administering allopregnanolone to the brains of NP-C mice. The effect was equally pronounced. In a series of experiments, the drug was given progressively early in the animals’ lives, at 21 to 23 days of age in the first mice examined, at 7 days of age in the last mice evaluated. The response, in terms of stalled neurological deficits, cellular damage and death, was greater the earlier the administration of the neurosteroid.

Dramatic Results

The most dramatic results reported were in mice treated with a single injection at seven days of age. They gained weight steadily until age 86 days, and lived to a mean age of 124 days. In contrast, untreated NP-C mice had a mean survival of 67 days.

In still more notable results, the researchers cited, but did not report, in their published paper that several treatments beginning at day seven in the animals’ lives extended their lifespan and delayed the onset of neurological impairment even further.

"The finding suggests that allopregnanolone may be involved in a neurodevelopmental process that occurs within or before the first week of life," says Mellon.

NP-C is an autosomal recessive disease, meaning both parents must contribute a copy of the mutated gene to cause the disease, and that there is a 25 percent chance their offspring will develop it. As infants suspected of having the disease can be tested to see if they carry the mutated gene, the disease can be detected early. Thus, if allopregnanolone proves effective in humans, it could be used to stall the disease from the outset.

The obvious next challenge for the researchers, however, will be determining how brain development of the mouse compares to that of the human.

Co-authors of the study were Lisa D. Griffin, MD, PhD, formerly UCSF assistant professor of neurology, Wenhui Gong, MD, PhD, a postdoctoral fellow in the Mellon lab, and Lucie Verot, PhD, graduate student in the laboratory of Marie T. Vanier, MD, PhD, of INSERM, U189 and Laboratoire Foundation Gillet-Merieux, Lyon-Sud Medical School and Hospital, Pierre-Benite, France.

Jennifer O’brien | EurekAlert!
Further information:
http://www.ucsf.edu

More articles from Studies and Analyses:

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

nachricht Pan-European study on “Smart Engineering”
30.03.2017 | IPH - Institut für Integrierte Produktion Hannover gGmbH

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

NASA laser communications to provide Orion faster connections

30.03.2017 | Physics and Astronomy

Reusable carbon nanotubes could be the water filter of the future, says RIT study

30.03.2017 | Studies and Analyses

Unique genome architectures after fertilisation in single-cell embryos

30.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>